SLU Study: Immune Dysfunction Increases Cancer Risk in Obese Populations
11/14/2024
ST. LOUIS —Researchers at Saint Louis University’s School of Medicine say T-cell dysfunction is leading to an increased risk of cancer in obese populations.
T cells are white blood cells called lymphocytes essential to your immune system in the fight against infections and cancer. Ryan Teague, Ph.D., professor of molecular microbiology and immunology at SLU, and his team are exploring why obesity impacts T-cell dysfunction and compromises immune surveillance, or the body’s ability to survey malignant cells and clear them before they become tumors.
Ryan Teague, Ph.D., left, and Alex Piening, an M.D./Ph.D. graduate student at SLU, work in the lab in Doisy Research Center on October 21, 2024. Photo by Sarah Conroy.
The study, which was led by Teague and co-authored by Alex Piening, an M.D./Ph.D. graduate student at SLU, was recently published in Nature Communications, found that T-cell dysfunction linked to obesity prevented T cells from detecting tumor cells, placing obese mice at higher risk of developing tumors when exposed to a carcinogen. Teague and his team are now trying to uncover the exact mechanism underlying the metabolic dysfunctions associated with obesity that directly impact T-cell function.
Ongoing projects in Teague’s lab at SLU are designed to identify barriers to successful cancer immunotherapy and develop strategies to overcome these barriers for improved patient outcomes. Teague and his team investigate how obesity impacts the efficacy of immunotherapies.
"Immunotherapy boosts a patient's immune system by targeting T cells and reinvigorating them. Paradoxically, immunotherapy is often more successful in patients with obesity, where the immune system isn’t functioning quite as well," Teague said. "Our research explains this paradox by showing that in the setting of obesity, developing tumors are only required to escape a weakened immune system. Such outgrown tumors are not well adapted to evade the reinvigorated T cells elicited during immunotherapy, and thus, are more easily destroyed."
Teague said single-cell RNA sequencing played a critical role in the study’s findings, which allowed scientists to learn what’s happening inside individual immune cells within tumors.
"We learned that the dysfunction in these T cells lies in their inability to kill tumors. Those genes were not being turned on. It also lies in their inability to acquire the metabolic functions needed to sustain anti-tumor activity," Teague said.
Thanks to SLU’s investment in single-cell RNA sequencing technology, the Department of Molecular Microbiology and Immunology has leveraged this new approach to advance its work studying cancer and the immune system, bringing us closer to new cures.
Other authors include Kelly D. Pyles, Kyle S. McCommis, Ph.D., Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine; Emily Ebert, Carter Gottlieb, Niloufar Khojandi, Lindsey M. Kuehm, Stella G. Hoft, Richard J. DiPaolo, Ph.D., Stephen T. Ferris, Ph.D., Elise Alspach, Ph.D., Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine.
Latest Newslink
- Two Companies Led By Saint Louis University Alumni Awarded 2025 Arch GrantsTwo firms led by Saint Louis University alumni received 2025 Arch Grant awards. GenAssist, led by Gabe Haas (SSE ’20) and co-founder Joe Beggs, and Decodable Reads, led by Paul Heinemann (A&S ’18) and Joe de Lorimier (CSB ’19), are part of a cohort of 19 new businesses receiving Arch Grants funding this year. GenAssist was one of four companies in SLU’s inaugural New Venture Accelerator (NVA) cohort in 2024.
- SLU Students Commemorate Legacy of Gift Body Donors at Memorial ServiceStudents from Saint Louis University’s School of Medicine Class of 2029, along with graduate students from the SOM's Master of Anatomy program and the Doisy College of Health Sciences, recently gathered for an interfaith memorial service to honor 355 individuals who generously donated their bodies to SLU’s Gift Body Program.
- SLU's Flying Billikens Secure Spot in 2026 National Intercollegiate Flying CompetitionA team of aviation science students from Saint Louis University’s School of Science and Engineering placed high enough this weekend to secure a spot in the 2026 National Intercollegiate Flying Association (NIFA) Competition. This is the third straight year the team has qualified for the national competition.
- Frequent Heartburn May Signal Risk for Alcohol Use Disorder, SLU Study FindsA new study from Saint Louis University reveals that individuals with frequent heartburn—clinically known as gastroesophageal reflux disease (GERD)—have a higher chance of being diagnosed with alcohol use disorder within two years. Researchers are urging primary care providers to screen GERD patients for alcohol misuse during routine visits.
- St. Louis Literary Award Events to Kick Off with Screening of “The Namesake,” Talk with Director Mira NairSaint Louis University will welcome Pulitzer Prize-winning author Jhumpa Lahiri to campus in 2026 to receive the St. Louis Literary Award. Literary Award programming kicks off the week of Oct. 27 with a showing of the film "The Namesake" and a discussion with director Mira Nair.
- SLU Hispanic Studies Professor Named Distinguished Visiting Professor in the Humanities at East Carolina UniversityAmy E. Wright, Ph.D., professor of Hispanic Studies at Saint Louis University, has been named the David Julian and Virginia Suther Whichard Distinguished Professor in the Humanities at East Carolina University. She will hold the visiting Whichard professorship in ECU’s Thomas Harriot College of Arts and Sciences for two years before returning to SLU.
